Neogene Co-Founder and CEO Carsten Linnemann, PhD, AstraZeneca has agreed to acquire Neogene Therapeutics for up to $320 million cash, the companies said Tuesday, in a deal intended to bolster the ...
AstraZeneca has dropped the lead candidate from its $200 million buyout of Neogene Therapeutics as part of a wider cell therapy clearout. When AstraZeneca scooped up the company back in 2022, ...
(RTTNews) - AstraZeneca Plc. (AZN.L, AZN) said that it agreed to buy all outstanding equity of Neogene Therapeutics for a total consideration of up to $320 million, on a cash and debt free basis. The ...
T-cell therapy company Neogene Therapeutics is being purchased by multinational pharma giant AstraZeneca in a deal potentially worth as much as $320 million that could greatly strengthen the regional ...
AstraZeneca AZN announced an agreement to acquire private biotech, Neogene Therapeutics to build its pipeline of cell-based cancer medicines. The acquisition of Neogene will provide AstraZeneca access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results